Prospetive evaluation of the risk of compartmental intra-abdominal pressure on mortality in severe acute pancreatitis

doi:10.21203/rs.3.rs-3082897/v1

Download PDF

Research Article

Prospetive evaluation of the risk of compartmental intra-abdominal pressure on mortality in severe acute pancreatitis

https://doi.org/10.21203/rs.3.rs-3082897/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted

You are reading this latest preprint version

Background

Death in the hospital is significant in patients with severe acute pancreatitis (SAP). They have elevated intraabdominal pressure (IAP), which might result in organ dysfunction. The study's goals were to look at the overall incidence of rising IAP in SAP patients as well as the progression of organ dysfunction and risk mortality factors for higher IAP.

Methods

Between 2020 and 2023, 118 cases of acute pancreatitis were managed in Zagazig University Hospital's intensive care unit (ICU). Patients were categorised into quartiles 1–4. The intravesical technique was used to assess elevated IAP.

Results

Peak IAP, max SOFA score, max APACHE II score, top creatinine, and age, with lactate peak level, were substantially related to IAP and higher in nonsurvivors. The maximal IAP in retrospective groups 1–4 was 7–14, 15–18, 19–24, and 25–33 mmHg, correspondingly, with hospital mortality rates of 10%, 12.5%, 22.2%, and 50%. Respectively, with significant statistics. The highest quality of ICU-free days was 45.7, 38.8, 32.0, and 27.5 days, respectively. Categories one to four have significant statistics.

Conclusion

Greater IAP in SAP cases presented with early organ damage and fewer ICU-free days. IAP is assessed throughout ICU inpatient care to prove the cure rate after decompression.

IAP

SAP

decompression methods

the mortality rate

Despite progress in managing severe acute pancreatitis, hospital deaths are still significant [1, 2]. The bacteria's virulence, the degree of damaged pancreatic parenchyma, and the presence of multiple organs (MOF) are the leading predictors of death [3]. According to the present research, some people who died of "early MOF" may have suffered from uncontrolled acute compartment syndrome (ACS). Massive revived fluids early in the disease, combined with the great inflammatory process, subsequent visceral edema, and fluid collection, increased intraabdominal pressure (IAP) [4].

IAP normally ranges from 0–5 mmHg, auscultated with respiration; patients with a pressure of 15 mmHg are more susceptible to organ dysfunction; a pressure of 20 mmHg causes compartment syndrome; pressures higher than 25–30 mmHg is linked to severe acute pancreatitis and organ failure [5, 6,7–11]. The worst value from each day was used to calculate the Sequential Organ Failure Assessment (SOFA) score [12, 13], which quantifies the degree of organ dysfunction. Regarding the IAP score, the patients were divided into quartiles 1–4.

SAP is one of the conditions that routinely have IAH and ACS documented. According to one study [14, 15], the incidence of IAH using the original Atlanta criteria was between 60 and 80 per cent, and ACS developed in around 25–50 per cent of the patients. The incidence of severe illness may be even greater with the new criteria, as some patients with what is now called moderate pancreatitis were previously classified as severe. A recent comprehensive study highlighted acute pancreatitis as a risk factor for IAH, but multiple additional variables are frequently present in SAP patients (16).

Numerous investigations on ACS in patients with SAP were described lately however information on this issue is still lacking [3, 10–13]. This investigation will concentrate on the therapeutic management of this dangerous illness because there are still many unanswered problems regarding medical therapy, evidence, execution, and interventions

Over the last few decades, there have been significant breakthroughs in understanding the pathogenesis, diagnosis, and therapy of IAH and ACS. The relevance of IAH in critically ill patients has been explicitly researched, leading to an improved understanding of the mechanisms of organ dysfunction caused by situated IAP and earlier opportunities for therapies. Furthermore, therapeutic and minimally invasive procedures have been developed and shown in limited research to be possibly beneficial [17].

For ACS during SAP, there is absolutely no accepted medical, surgical, intervention other therapeutic cure. IAH and ACS classifications and therapy guidelines have been released by the World Society of Abdominal Compartment Syndrome (WSACS) [6], but it is unknown if SAP individuals can use these guidelines.

In all reports about this condition, IAH, particularly ACS, has been linked to a poorer outcome [2, 5, 7, 12, 17]. Rosas et al. even proposed using IAP as a marker of severity in SAP; in their analysis, using a cut-off of 14 mmHg, the receiver operating characteristic curve of IAP was higher than the Ranson and Imrie score, which could make IAP measurement a simple tool [18]. However, no other studies have evaluated IAP for this purpose

Prospective individuals with SAP treated at ICU Zagazig University Hospital between 2020 and 2023 were identified using the ICU automated database board sheet system, and at least one organ malfunction confirmed the diagnosis clinically and by CT. In 74 of 118 people, if IAH was acutely anticipated due to excessive distension of the abdomen paired with either early or deteriorating organ failure, IAP was used to evaluate

2.1 | intra -abdominal pressure (IAP) recording :

At 4-hour intervals, intravenous pressure was recorded in a supine position at the end of expiry using a Foley catheter with a three-way stopping cock. IAP was recorded every 4 hours on the day of enrollment, and peak IAH values were obtained. A constant rise in IAP was regarded as a boost in not less than three successive calibrated readings. Patients were split into two groups (A and B) depending on the presence or absence of IAH (IAH-IAP >12 mmHg) based on their highest IAP values

2.2 | Interventional Therapy

Intervention procedures appear to be needed when medical assistance for IAH is ineffective and ACS has already manifested. Percutaneous draining catheter (PCD) insertion following radiological guidance ought to represent the initial line of treatment for these individuals to alleviate ACS [19–22]. Sun et al. [20] found that the intra-ab had a significant association with drainage systems volume, length of hospital stay, and APACHE II score in an assigned study assessing the impact of implanted catheters and conservative measures in the management of ACS in intense severe pancreatitis. Participants with abdomen catheters fared far more well compared to those who received conservative treatment in terms of outcomes (relief of abdominal discomfort and length of hospitalisation stay). It was not significantly different than the rate of fatalities was reduced from 20.7% to 10% as recorded.

2.3 | Times of Invasive Therapy

On the best surgical intervention for patients with ACS during SAP, there remains no definite agreement. There is a lack of information on the best surgical technique, signalling, and time for these individuals. Decompressive laparotomy is "recommended in instances of explicit ACS compared to strategies that avoid the use of decompressive laparotomy," according to the WSACS clinical practice guidelines. [6]. There is no discussion of the best method for a laparotomy or what obvious ACS entails (amount of IAP, the extent of root causes, etc.).

The time of abdomen decompression in the care of these individuals is still unknown. Outcomes unmistakably showed that the initial decompression (during the first four days) was associated with significantly fewer deaths than delayed decompress (during the following four days).

In an attempt to enhance the outcomes of patients who develop ACS during SAP, numerous approaches to surgery have been outlined in the most current scholarship. Several documented processes might be helpful and appropriate for these people. The most popular procedure for treating ACS is decompressive laparotomy with concurrent laparostomy [2, 7, 10-13, 16,]. Midline incisions are the procedure that is used the most frequently to do a full-thickness laparostomy [23]. Nevertheless, other writers claimed that dual subcostal incisions may have benefits, such as making abdominal wall rebuilding simpler and safer [10, 24]. The abdominal wall is primarily repaired throughout the two procedures utilising a method for transient abdominal closure. Numerous types of abdominal zippers, plastic silo bags (Bogota bags), and vacuum-assisted closed structures were employed for this purpose. When compared to leaving the belly open, partial abdominal sealing has some benefits, including preventing fascia edge retracting, preserving the abdominal domain, and preventing the occurrence of "acute abdomen" [25].

The main objective of decompressive laparotomy in the treatment of ACS is to achieve basic fascia closure. According to WSACS recommendations, protocolized measures should be made to complete a fascial repair as soon as possible [6].

2.4 | conservative Management for all critically ill and ICU cases

2.4.1 | optimise Fluid Administration

Proper volume therapy is crucial to preventing IAH and ACS in severe AP. Getting the best systemic infusion possible with the appropriate fluid delivery is a crucial part of treating acute pancreatitis. To reestablish end-organ perfusion in cases of acute pancreatitis, some recommendations advise swiftly augmenting with isotonic crystalloid solution [21,22,23]. The person's susceptibility to volume resuscitation, the length of duration following the start of pancreatitis (a minimum of 24 h is essential), and the individual's susceptibility to fluid sequestering ought to be taken into consideration. The intensive-care physician is crucial at this stage in reversing hypovolemia and avoiding iatrogenic abdominal compartment syndrome. Critically ill patients' fluid requirements frequently change throughout their illness, therefore hydration must be modified as necessary [26]. In response, Malbrein's team developed the ROSE concept, which divides distributing fluids into 4 stages: the rescue phase, the optimisation phase, the stabilisation period, and the release stage [27].

Following an early enthusiasm for active fluid therapy, it quickly became apparent that intensive resuscitation for more than 48 hours following the start of pancreatitis increases mortality by causing the development of abdominal compartment syndrome [27,28,30]. Beginning violent fluid administration (a bolus of 20 mL per kilogramme of weight of the individual after 3 mL per kilogramme per hour) led to an increased likelihood of excess fluids lacking improving clinical results in a very current randomised trial involving patients with acute pancreatitis, according to the evaluation involving 249 patients [29,31]. A more individualised approach is necessary due to the danger of under-resuscitation when a predetermined infusion rate is used and the risk of injury whenever fluid treatments are given too aggressively [18]. Hemodialysis and the usage of loop diuretics should also be taken into consideration [55].

2.4.2 |-antibiotics

Due to bacterial translocation and decreased immune function in early phases, individuals suffering from necrosis severe pancreatitis are more likely to contract the infection and may experience infected pancreatic necrosis 2-4 weeks after the disease first manifests [32]. Due to the possibility of bacteremia, the experimental application of antibiotics is advised in patients who experience organ failure during severe AP rather than the preventative use of antibiotics [32,33,34]. Antibiotics have been treated as shown to be misused and used unduly contrary to advice [35,46]. The chance of infections encountered in hospitals rises when antibiotics are misused. The subset of those who benefit most from timely prescription antibiotics is identified by initial increased inflammatory markers [37,38]. Antibiotics must be given since individuals who advance to IAH are susceptible to contracting sepsis [8,39].

2.4.3 |-energy and nourishment

For the purpose to preserve its advantages about the transmission of bacteria, widespread infection, organ failure, and immortality, it is advised that it is not postponed for longer than 48 hours. The nasojejunal tube should be used to administer the general diet at an average rate of 10 mL/h, according to recommendations [40]. Since bacterial proliferation and transfer are less likely with feeding through the gut, hypertension inside the abdomen is avoided [16,38]. In individuals with abdominal compartment syndrome, feeding through mouth ought to be stopped and complete parenteral nourishment should be started

All patients received standard care, involving nasogastric decompression in various IV fluids, analgesics, and other complementary prescribed medications. During assistance, antibiotics were decided upon based on the possibility of sepsis and the existence of culture and sensitivity reports. If necessary, ventilatory aids and vasopressors were provided. Unless not recommended, dietary assistance was possibly enteral. The APACHE II score was obtained at the time of admission. During the first seven days after being admitted, the SOFA score was employed to diagnose organ failure. When a substitute conservative technique to minimise IAH was unsuccessful, surgery occurred earlier on and subsequently in patients who weren't receptive to a boost strategy

2.4.4 |-Medical drugs for Intraluminal pressure decline

He et al. [27] recently conducted a

randomised controlled trial to gauge the success rate of neostigmine in minimising IAP in AP with IAH. Neostigmine was taken IM at BID and raised to 1 mg every 8 or 6 hours if that aware faeces IAP fell at a much faster rate in the neostigmine group. Neostigmine was swiftly effective, declining IAP 3 hours following one injection. In 24 hours, IAP declined by around 20%. The neostigmine group had a larger faeces quantity across the 7–14-day monitoring session. By the fourth day, the treated group had experienced early pain alleviation and an important reduction in IAP (from 14 to 6 mmHg) and APACHE II score [30].

2.4.5 |- other medical tmentsment of IAH/ACS in AP

Numerous therapy techniques for IAH and ACS can be classified based on the basic mechanism that boosts IAP. Other factors are generally associated with them; therefore, such measures are not distinct. Comparably, since IAH is a process, therapies can be either preventative measures or curative. The degree of endorsement in the WSACS mainstream can, at times, be weak or absent because of early clinical pictures [22]. There have been no trials that show the effect of sedation on IAP. Nevertheless, the WSACS suggestion for appropriate stress and agony in IAH continued. Analgesics are also essential in the treatment of difficult conditions such as AP. Cisatracurium injection has been proven to decline IAP in cases with IAH-attributed water collection, gut injuries, or burning. Brief trials of muscarinic therapy have been demonstrated to be secure and efficient in treating critically ill patients, especially IAH [19,-41].

The algorithm of medical treatment shown in Figure 1

definitions by Kirkpatrick et al., Clinician’s Guide to Types of Management in a severely ill patient

The most recent manuscript described and updated in 2013 is shown in Table 1 [7, 25].

Table 1: definitions in a Clinician’s Guide to Management of IAH and ACS in Severely Ill Patients

No.	Definition
1.	The steady-state pressure buried within the abdominal cavity is referred to as IAP
2.	The bladder is used as the source basic for paroxysmal IAP value, with a max infusion amount of 25 ml of saline
3.	IAP by (mmHg) at the end of expiration in the supine posture, with zero transducers at the midaxillary line
4.	In critically unwell people, IAP is around 5-7 mmHg.
5.	A continuous or recurring pathological IAH is defined as an increase in IAP of 12 mmHg.
6.	Acute comp. syndrome (ACS) is known as a continuous IAP of > 20 mmHg regardless of the APP of 60 mmHg), which may be correlated with emerging organ dysfunction/failure
7.	The IAH score is as the following:

	Grade one IAP 12-15 mmHg

	In Grade Two, the IAP is 16-20 mmHg.
8.	Basic IAH, referred to as ACS, is a disorder that involves abdomen or pelvis damage or disease that frequently demands early surgeries or invasive radiological therapy.
9.	Second, IAH, frequently referred to as ACS, is a term used to describe disorders that do not start in the abdominal region.
10.	Recurrent IAH or ACS occurs when IAH or ACS reappears after previous surgical or therapeutic management of the main or second IAH or ACS.
11.	APP = MAP – IAP
12.	When compartmental pressure occurs in multiple anatomical, compart is called a poly-compartment syndrome.
13.	The ease with which the abdominal wall and diaphragm can broaden is termed abdominal compliance. The alteration in IAP per increment in intra-abdominal capacity should be given.
14.	Because the skin and fascia were not connected after the procedure known as la, the open abdomen demands a temporary abdominal closing.
15.	Shifting of abdominis to the lateral side by which the musculature and fascia of the lining of the abdomen, most notably the rectus abdominis muscles and their enveloping fascia, migrate laterally farther from the centerline over time.

2.5 | surgical treatment of central-abdominal collection treatments

Abdominal drained fluid: 2900 cc. The rate of cyst formation was also reduced, as was the relief of abdominal discomfort and inpatient time [26,42].

A decrease in IAP occurred gradually after many days (7–14 days) of pain-relieving and organ function improvement. He et al. compared percutaneous catheter drainage to peritoneal lavage in 86 individuals with SAP in a randomised controlled experiment. Fluid-filled toxin and cytokinesis: there is no statistical difference between both methods except for the rapid decline of IAP in the first 3 days after catheter drainage. At the same time, the intraperitoneal lavage group experienced an increase [27,43].

Fluid Balance and Capillary Leak Therapies

According to some research, hemodialysis and hemofiltration prevent dilatation of the capillaries and diminished fluid recollection. Some authors discovered a decline in IAP and IL-6 levels in 17 people with AP who received therapy with continual hemodiafiltration [37]. Xu et al. reviewed 25 cases with SAP and ACS who received CVVHF; one day passed, and IAP was minimised by Numerous therapy techniques for IAH and ACS. The authors stated that removing humoral mediators upgraded the prognosis but, Therefore, required additional information on fluid equilibrium [44]. Pupelis et al. discovered that in a retrospective examination of 75 AP patients who received CVVHF versus 55 who did not, therapy outcomes declined in terms of infection, negative fluid balances, and shorter inpatient timing [29].

There is the suggestion that prompt decompression may improve mortality after adjustable surgical decompression, which would end the ACS cycle [9,19,45]. The inability of the rehabilitative method is significantly attributed to permanent intestinal injury that was detected prematurely [9,12]. A decompression procedure was advised by several writers to be carried out between a few hours and four days following the identification of abdominal compartment syndrome

(Table 2). Decompensated pulmonary or heart failure necessitates rapid decompression using surgery because of the dire outcome and lack of other therapies [46,47,48].

Table 2: shows the surgical management options for compartment syndrome of the abdominal wall in the backdrop of acute severe pancreatitis[48]

First Author (Year)	Severe AP		IAH		IAH—Male (%)		ACS		Interventions		% Interventional Treatment of ACS		Time to Intervention		ACS Mortality
Tao (2003) [123]	345		2		14 (67%)		21		Midline laparotomy with Bogota bag (n = 18)		85.7		9–22 h		33.30%
De Waele (2005) [124]	44		21		15 (71%)		4		Midline laparotomy, temporary abdominal closure system (n = 4)		100%		-		75%
Chen (2008) [8]	74		44		23 (52%)		20		Percutaneous abdominal decompression and drainage (n = 8); Decompressive emergency laparotomy (n = 8)		65%		26–33 h		75%
Mentula (2010) [28]		26		0		23 (88%)		26		Open abdomen (n = 21) Subcutaneous linea alba fasciotomy (n = 5)		100%		1–5 days		46%
Bezmarevic (2012) [12]		51		27		23 (79%)		6		Midline laparotomy (n = 6)		83%		1–4 days		83%
Davis (2013) [11]		43		16		16 (100%)		16		Midline laparotomy with Bogota bag (n = 11) or wound VAC system (n = 5)		100%		3 h		25%
Peng (2016) [117]		273		273		168 (62%)		273		Midline laparotomy (n = 61) Percutaneous catheter drainage (n = 212)		23.30%		2–101 h		52.50%
Smit (2016) [9]		59		29		21 (72%)		13		Transverse subcostal laparotomy (n = 7), midline laparotomy (n = 3)		10 (77%)		1.9–15.5 days		53%

Data were collected retrospectively from, the computerised medical database for health records Demographics and gender, BMI, length of hospitalisation in an ICU, the quantity of ICU-free days (out of 60), period of residential again, fatality at the care facility, medical records, the disorder of pancreatitis, and what kind of hospitalisation (original or referral) have been compiled. IAP laboratory investigation requires supplementary therapy for kidney failure, the quantity of solution given, fluid balance, the quantity of fluid in the abdomen (degrees I, II, and III according to amount; measured with CT), the degree of daily measured SOFA, and the APACHE II score (days 1–14 in ICU).

SPSS (Statistical Package for Social Sciences, version 12.01, Chicago, IL, USA) was employed for statistical analysis. Spearman's non-parametric relationship was utilised to analyse parameter interactions. Based on their highest IAP, participants were split into quartiles. The Kruskall-Wallis test has been employed to determine the statistical significance of continuous variables across various categories.

The Fisher exact test was put to use for variable dichotomy. To establish the significance of the two groups, the Mann-Whitney test was used. The data presented is offered in the form of medians with interquartile (IQ) ranges. The mean number of ICU-free days out of 60 is given. Statistical importance is characterised by a p-value of 0.05 or less.

The hospital mortality rate in the experiment's group was 24% (18 out of 74); regarding the WSACS identification, the determination of IAH was 84% (62 out of 74) of participants. 34/74 (46%) of individuals had recurrences of IAH. ACS struck 36/74 (49%) of the patients, with recurrent ACS striking 14/74 (19%). (Table 3) outlines the demographic and physical information for survivors and nonsurvivors. The age of the participants was 46 years (range 21–69 years), and gallstones were the majority cause (84%). Ten patients had abdominal surgeries in the first two weeks in the ICU, followed by eight more. Four of the laparotomies done throughout the study period were due to ACS. After surgery, in two cases, IAP dropped from 34 mmHg to 17–23 mmHg. Within 24 hours, the decline of IAP started (figure 7). Urine flow rate grew from 1 ml/kg/h to >2 ml/kg/h, lactate levels normalised, and lung improvement occurred. After surgery, four individuals dropped their IAP from 25 to 13 mmHg. Urine flow rose from 0.5 randomised kg/h, and lung improvement In each of these individuals, the effects of IAP lasted several days. Intra-abdominal haemorrhage, attainable bowel perforation, and proven or suspected peripancreatic necrosis infection were additional warrants to consider laparotomy. 43% (32 of 74) of the patients required substitute kidneys. The mortality rate was 18% for the 22 patients whose IAP was not assessed.

Table 3: displays the clinical and demographic features of patients with SAP.

	All (%)
	54 (100)
Male	66 (89)
Median age / yel	46 (21–69)
Medium BMI	28 (21–42)
History of comorbidity
High blood pressure	20 (27)
D.M	4 (5)
Heart D.	6 (8)
Hyperlipidemia	4 (5)
Chronic pancreatitis	2 (5)
COPD	4 (5)
Kidney	4 (5)
Psychological D	8 (11)
Cause
Gallstone	62 (84)
Biliary	12 (16)
Fluid quantity by CT
small	26 (35)
moderate	38 (51)
large	8 (11)
Balthazar degree
A, B	0 (0)
C	2 (3)
D	2 (3)
E	68 (92)
no CT	2 (3)
Primary admission	8 (11)

CT stands for computed tomography, an acronym for a person's body mass index.

Nonsurvivors had substantially higher max IAP, max APACHE II, max SOFA score, advanced age, the peak of lactate levels, top creatinine levels, and baseline deficiency in ICU data (Table 4 ); minimising IAP had a substantial connection with a positive SOFA score (coefficient 0.49, p = 0.0), the relation link between peak intra-abdominal pressure (IAP) and the maximum (SOFA) score in survivors and nonsurvivors of severe AP (Fig. 2).

Table 4: shows ICU data from survivors and nonsurvivors of SAP.

	Nonsurvivors	Survivors
	Median (IQ range)	Median (IQ range)	p-value
IAP peak (mmHg)	25 (19.4–27.4)	18 (13.3–22.8)	0.043
SOFA max	14 (12.6–16)	10.5 (7.3–11.8)	0.003
ICU stay (days)	27 (7.10–54.10)	15.5 (7.3–20.8)	0.257
Hospital stay (days)	28 (9.15–107.15)	26 (20.0–37.5)	0.986
CRP at admission (mg/l)	293 (211–384)	316 (246–377)	0.671
APACHE II	19 (17.0–22.5)	13 (10.0–17.0)	0.001
Lactate max (mmol/l)	2.7 (2.1–7.1)	1.5 (1.3–2.1)	0.006
BE min (mmol/l)	-10.5 (-13.2-(-8.0))	-1.3 (-6.6-(-1.3))	<0.001
Creatinine max (mmol/l)	338 (181.5–546)	140.5 (67.5–280.13)	0.020

On ICU days 1–7, nonsurvivors had the peak IAP, APACHE II, at the hospitalisation. Top SOFA and maxi were lactate, the highest creatinin, and base deficiency were substantially rising in nonsurvivors (Table 4; there was a strong association of the highest IAP with the optimum SOFA score (the coefficient 0.49, p = 0.001, figure 3).

There was no notable appearance of SOFA in lung disease, kidney function, hospitalisation, or coagulation disorders (no data evidence was provided). proved that nonsurvivors had higher total IAP, overall SOFA, SOFA cardiovascular, and renal scores on ICU days 1–7 than survivors . Cases were split into quartiles (18–20 cases per group) according to their highest IAP evaluation during days 1–14 in the ICU, with the highest IAP values spanning 7–14, 16–18, 19–24, and 25–33 mmHg in categories 1–4. Overall mortality rates in groups 1-4 were 10%, 12.5%, 22.2%, and 50%, respectively. The highest point SOFA score (p = 0.01), creatinine levels (p = 0.01), time spent in critical care (p = 0.038), and top lactate values (p = 0.039) were also extremely significant (Kruskall-Wallis test). The variation in mortality rates (1 and 4) was not deemed significant (p = 0.14; Fisher exact test). In groups 1-4, the mean ICU-free days were 45.7, 38.8, 32.0, and 27.5 days, respectively (p = 0.045, Kruskall-Wallis test). The distinction in ICU-free days within groups 1 and 4 had significance based on p = 0.023, Mann-Whitney test. (A p-value of 0.05 or less characterises statistical importance.) ROC (receiver operating characteristics) curves for IAP max days 1–7, SOFA day 1, and APACHE II are shown in Figure 4.

ROC curves for IAP max days at the day of surgery were raised at 40-45 mmHg after the start of the disease

7.4 kg reduction for 27 hours after drainage of 3.48 L for early 9 hours and IAP reduction during first 20 hours

Comatosed patient became alert after the Procedures as shown under ROC cure Figure 4

In the present investigation, researchers discovered that high IAP correlated with organ failure and an extended stay in intensive care units in extremely sick patients with SAP. IAP augmentation is hazardous for all systems of organs. Reduced cardiac activity, ventricular volume at end-diastolic preload, and venous return, as well as venous dilatation.

defects in preload and intrathoracic pressure [14, 31,49]. The absence of breath is triggered by diaphragm elevation, which causes a decline in all respiratory parameters and a ventilation-perfusion mismatch that is normalized and important for artificial ventilation. Renal dysfunction is associated with the decline of perfused blood because of the pooling of the blood at the periphery because of capillary and venous dilation; also, the cause of cardiac failure is the decreased venous return because of venous dilation and failure to output; the most likely explanation for the splanchnic infarction is that vasopressin levels might play a role in the progression of splanchnic infarction [27–48]. Systematic evaluation of severely deteriorated persons by classifications such as APACHE II [19] and SAPS was used [49,50–57]. Contrary to this, IAP is not involved in these

The most common trigger cause of AP is alcoholic beverages (25% in Europe), but in our study, the most common cause of AP is gallstones pancreatitis (84%.

Previous work has related an increase in IAP to an increase in mortality in postoperative and trauma patients. Acute ACS has been linked to multiorgan malfunction and a rise in mortality in trauma patients and individuals with liver transplants. In recent multicenter research, the mean ICU-free days declined considerably as peak IAP increased in the quartiles stratified by maximal IAP. Recently, IAP was assessed when IAH was anticipated in SAP patients, and the frequency of IAH was 78%. This is supported by our findings that 84% of our participants had IAH. In the present study, non-survivors maintained their IAP throughout their first week in the ICU, whereas survivors' IAP diminished. The SOFA score for non-survivors remained virtually unchanged. This could imply that IAP in SAP patients is a significant gauge of poor consequences. A more comprehensive inspection, however, must be conducted to prove that result.

The Sequential Organ Failure Assessment (SOFA) score [2, 36] was the degree of organ dysfunction; depending on the measure of the IAP score, the patients were divided into quartiles.

According to those characters, the chance of IAH in SAP is greater than 60%, whereas the prevalence of ACS in patients admitted to a critical-care unit ranges from 10–30% [8, 9]. IAH is almost nonexistent in those with moderate AP [10].

IAH hazards the progression of SAP. Due to increased fluid collection because of highly dilated capillaries, the leading factors displayed in Table 5

Table 5

Factors affecting capillary leakage and excessive fluid collection.
Eventually, Present in the AP	Mechanism
Pain Edoema of the abdominal wall Obese	the Determinants reducing abdominal wall compliance
Gastroparesis Ileus Ascites Edoema with retroperitoneal hemorrhage Acute fluid accumulations	Instances that rose abdominal contents
Massive overloaded fluid SIRS/MODS	DThatminants that increase capillary permeability and fluid Leake

IAP wasn't tracked for all SAP patients in our ICU during the inquiry term, which represented an oversight. Moreover, there was a limited patient population to explore the predictive impact of several variables on the clinical result. However, the negative impacts of high IAP on various systems of organs have been demonstrated, and IAH may be an obstacle to poor organ performance (SOFA score) in SAP patients.

Because high IAP has been tied to bacterial translocation in animal studies [36, 37], IAH may be especially dangerous to those with severe AP. A combination of widespread splanchnic inadequate perfusion, the restricted blood supply to the pancreas, and bacterial translocation with subsequently necrotizing pancreatitis with bad results [39]. While the function and therapy of IAH in SAP are uncertain, IAH and CS are not explicitly addressed in the latest international guidelines for managing severe acute pancreatitis [38, 40].

Although the primary data comes from retrospective case studies, the trends are clear: AP patients with IAH or ACS are more likely to have organ impairment [11, 12, 41, 42, 43]. IAH is a common first-day symptom of SAP. It usually appears alongside or before other systemic disorders, and in those who improve, it tends to normalise. Sustained IAH, especially ACS, has been linked to mortality [12, 13, 44]. It is estimated that ACS kills between 30 and 60% of those who contract it. Despite initial improvements, mortality approached 50% in 12 patients requiring decompressive laparotomies [5, 14, 15, 45, 46].

A thorough midline procedure is

typically necessary for decompression with surgery in people with ACS who are worsening and who have trouble responding to medicinal treatment. Regardless of the basic reason, decompressive laparotomy is particularly helpful in lowering the IAP for those having ACS [13,47], and this is another benefit seen in SAP. several operators are cautious about operating on those suffering from SAP before the progression of the disease because multiple research has revealed the initial operation in SAP was deleterious. The significance of decompressive laparotomy is still debatable. It's vital throughout a decompressive laparotomy should the pancreas not be disturbed.

For individuals who have SAP, options for midline laparotomy are being suggested. To do the subcutaneous linea white fasciotomy, Leppaniemi et al. made tiny skin cuts in the front abdominal cavity [22,48] Despite helping a lot of people avert middle laparotomies, the method has drawbacks, including the complicated by incisional hernias. In open laparotomies, facial sealing frequencies are boosted as a result of enhanced transient abdomen sealing methods. A few operators may favour a transverse cut in the case of SAP to allow further access to the pancreas

The exact time during surgery to decompress is a very fascinating subject. The researchers of a study on a group of people receiving decompression therapy in Finland found a 100% mortality rate among individuals who underwent the procedure more than five days after the onset of their symptoms [24]. It should not come as a surprise that organ dysfunction is permanently damaged in situations when there is extended exposure to high IAP. However, it is challenging to pinpoint the precise window of time within which decompressive laparotomy can be effective. Early intervention—as early as 6 hours following the onset of ACS—was found to be more beneficial by Ke et al. in animal research]50[

. Recent research proves that low-grade IAH is a less dangerous consequence than high-grade III-IV IAH and ACS, supporting the studies that earlier identification and handling of IAH contributes to easy management and improved outcomes.

When ACS has been identified, early therapy with surgical decompression is the best procedure, but the actual evidence, threshold IAP values, and the main other approaches need other research. It is even more critical given the procedure's high morbidity, especially when fascial sealing is difficult. It leaves an open abdomen with severe permanent complications and an urgent need for abdominal wall revision surgery. While, as established in traumatising persons and other interventions, prompt decompressive laparotomy may minimise the risk of organ dysfunction in patients with serious IAH who haven't responded to nonoperative therapy [18, 39, 40, 47], For those with severe acute pancreatitis, a similar result is to be anticipated.

In our study prostigmine was used in medical trials in ICU critically I'll patients, but neostigmine restrictions, in pregnant, and breastfeeding will disqualify participation. When both of the following three symptoms are present, AP is diagnosed: (a) Standard abdominal pain is defined as a sudden appearance of a persistent, painful epigastric area that frequently radiates to the back, which (b) serum amylase or lipid activity is more than three levels above the limits of routine; and (c) AP is detected on transabdominal ultrasound, contrast-enhanced CT, or MRI.[5] Different Strategies Research that contrasts traditional treatment alone against traditional therapy is acceptable. The standard course of treatment entails digestive decompression if required, painkillers, dietary encouragement, symptomatic relief, early revived fluids for IAH, and elements of Chinese medicine like rhubarb and Glauber's salt.[1 27]

IAH is a well-known scenario with many risk factors rooted in abdominal cavity physiology and systemic implications. There are relevant data to argue that IAH has a role in SAP and is not a natural phenomenon. Although the individual in question has gotten fewer spotlights than other SAP domains. The term AP refers to the overall and local factors that contribute to an elevated risk of IAH in severe situations. The influence on prognosis correlates with a boost in morbidity involving renal, pulmonary, and cardiovascular dysfunction, as well as mortality, especially among ACS patients. The IAH might have local consequences, like necrotizing infections. IAP detection is a low-cost and low-risk approach. The process is famous and widely used. SAP calculates IAP using a cost-benefit analysis. Consideration is given to individuals who are moderate to critically ill with the initial disease that occurred. Fluid regulation may be the most beneficial therapeutic strategy. This does not reduce the crucial significance of quick rescue for those who require it.

It could be noted that most cases of IAH and even ACS respond to conservative therapy, which should be encouraging in all circumstances. Refractory ACS, on the whole, could require surgical decompression due to higher mortality if not focused on promptly. Given that the typical incidence of ACS is essentially fatal, this procedure will always be challenging and could be influenced by different experiences. Advances in urgent care, the rationale of procedure diagnosis, early enteral nutrition, alert fluid use, and higher involvement in noninvasive treatments have all benefited the prognosis of AP, with overall death and morbidity rates reducing

IAH is virtually nonexistent in early acute

pancreatitis (MAP), whereas it is prevalent in SAP. IAH is a phenomenon that has a harmful clinical impact while also being a factor that may reveal a poor prognosis. As a result, IAH monitoring should be recognised regularly in the context of SAP, and attempts should be made to start early therapy to prevent rises and advancement to ACS. In patients with chronic pancreatitis, frequent IAP assessment during acute intensive care is crucial in controlling abdominal perfusion pressure while recognising individuals who might gain an advantage from an early decompressive laparotomy.

Ethics approval and consent to participate

The ethical committee of zagszig university, Egypt, approved the study. (every participant provided informed consent to participate in the study, The study was performed in accordance with the relevant guidelines and protocol of the Helsinki Declaration

Available data and materials The database and materials under our review with the corresponding author when you're requesting

All authors shared the database and work.

Consent of publication

Not applicable.

Competing Interest

The authors declare no conflict of interest.

Funding

No funding was received for conducting this study.

Acknowledgment is not applicable.

Corresponding author

Correspondence to Hassan A Saad

Authors affiliation

Hassan A Saad,

Ahmed El-Taher,

Heba Alhussein Abo-alella,,

Ashraf Abdelmonem Elsayed,

Mohamed Riad,

Mohamed E Eraky ,

Surgical Department, Faculty of Medicine, Zagazig University, zagazig city,Egypt

Corresponding author: Hassan A. Saad, Telephone: (+20)01221025689, ORCID: 0000-0002-6242-7823. E-mail: [email protected]

Authors contributions

HAS:Conception and design

Heba A: Development of methodology and Acquisition of data

AK: Analysis and interpretation of data,

AE: Writing, review, and/or revision of manuscript:

HAS,ME :Administrative, technical,

AK,AE,MR:material supportAll authors read , equally shared and approved the final manuscript

van Brunschot S, Schut AJ, Bouwense SA, Besselink MG, Bakker OJ, van Goor H, et al. Abdominal compartment syndrome in acute pancreatitis: a systematic review. Pancreas. 2014;43:665–74.
Jaipuria J, Bhandari V, Chawla AS, Singh M. Intra-abdominal pressure: time ripe to revise management guidelines of acute pancreatitis? World J Gastrointest Pathophysiol. 2016;7:186–98.
Kirkpatrick AW, Roberts DJ, De Waele J, Jaeschke R, Malbrain MLNG, De Keulenaer B, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013;39:1190–206.
Jacob AO, Stewart P, Jacob O. Early surgical intervention in severe acute pancreatitis: central Australian experience. ANZ J Surg. 2016;86:805–10.
Mentula P, Hienonen P, Kemppainen E, Puolakkainen P, Leppaniemi A. Surgical decompression for abdominal compartment syndrome in severe acute pancreatitis. Arch Surg. 2010;145:764–9.
Boone B, Zureikat A, Hughes SJ, Moser AJ, Yadav D, Zeh HJ, et al. Abdominal compartment syndrome is an early, lethal complication of acute pancreatitis. Am Surg. 2013;79:601–7.
Davis PJB, Eltawil KM, Abu-Wasel B, Walsh MJ, Topp T, Molinari M. Effect of obesity and decompressive laparotomy on mortality in acute pancreatitis requiring intensive care unit admission. World J Surg. 2013;37:318–32.
Muresan M, Muresan S, Brinzaniuc K, Voidazan S, Sala D, Jimborean O, et al. How much does decompressive laparotomy reduce the mortality rate in primary abdominal compartment syndrome?: a single-center prospective study on 66 patients. Medicine (Baltimore). 2017;96:e6006.
Banks P, Bollen T, Dervenis C, Gooszen H, Johnson C, Sarr M, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2012;62:102–11.
Mora-Guzmán I, Del Pozo Jiménez JA, Martín-Pérez E. Abdominal compartment syndrome secondary to acute necrotizing pancreatitis. Rev Esp Enferm Dig. 2017;109:538.
Svorcan P, Stojanovic M, Stevanovic P, Karamarkovic A, Jankovic R, Ladjevic N. The influence of intraabdominal pressure on the mortality rate of patients with acute pancreatitis. Turk J Med Sci. 2017;47:748–53.
Pupelis G, Austrums E, Snippe K, Berzins M. Clinical significance of increased intraabdominal pressure in severe acute pancreatitis. Acta Chir Belg. 2002; 102:71–4.
De Waele JJ, Ejike JC, Leppaniemi A, De Keulenaer BL, De Laet I, Kirkpatrick AW, et al. Intra-abdominal hypertension and abdominal compartment syndrome in pancreatitis, paediatrics, and trauma. Anaesthesiol Intensive Ther. 2015;47:219–27.
De Waele JJ, Hoste EA, Malbrain ML. Decompressive laparotomy for abdominal compartment syndrome--a critical analysis. Crit Care. 2006;10:R51.
Mao EQ, Fei J, Peng YB, Huang J, Tang YQ, Zhang SD. Rapid hemodilution is associated with increased sepsis and mortality among patients with severe acute pancreatitis. Chin Med J. 2010;123:1639
Malbrain ML: 16. Pinsky MR. Cardiovascular issues in respiratory care. Chest 2005, 128, 592S-597S.
Hebbard GS, Reid K, Sun WM et al. Postural changes in proximal gastric volume and pressure measured using a gastric barostat. Neurogastro.. Motil 1995, 7, 169–174.
Shuster MH, Haines T, Sekula LK et al. Reliability of Intrabladder Pressure Measurement in Intensive Care. Am. J. Crit. Care 2010, 19, e29–e39.
Al-Abassi AA, Al Saadi AS & Ahmed F. Is intra-bladder pressure measurement a reliable indicator for raised intra-abdominal pressure? A prospective comparative study. BMC Anesthesiol. 2018, 18, 69.
sun et al. A. Intra-abdominal pressure: an integrative review. Einstein 2016, 14, 423–430.
Reintam Blaser A, Regli A, De Keulenaer B et al. Incidence, Risk Factors, and Outcomes of Intra-Abdominal Hypertension in Critically Ill Patients-A Prospective Multicenter Study (IROI Study). Crit. Care Med. 2019, 47, 535–542.
Davis PJB, Eltawil KM, Abu-Wasel B et al. Effect of obesity and decompressive laparotomy on mortality in acute pancreatitis requiring intensive care unit admission. World J. Surg. 2013, 37, 318–332.
Smit M, Buddingh KT, Bosma B et al. Abdominal Compartment Syndrome and Intra-abdominal Ischemia in Patients with Severe Acute Pancreatitis. World J. Surg. 2016, 40, 1454–1461.
Finland P, Hienonen P, Kemppainen E et al. Surgical decompression for abdominal compartment syndrome in severe acute pancreatitis. Arch. Surg. 2010, 145, 764–769.
Kirkpatrick AW, Roberts DJ, De Waele J, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013;39:1190–206.
Ke L, Ni HB, Sun JK et al. Risk factors and outcome of intra-abdominal hypertension in patients with severe acute pancreatitis. World J. Surg. 2012, 36, 171–178.
He et al. Reduction of intra-abdominal pressureIAP after percutaneous catheter drainage of pancreatic fluid collection predicts survival. Pancreatology. 2020;20:772-777.
Mao EQ, Fei J, Peng YB et al. Rapid hemodilution is associated with increased sepsis and mortality among patients with severe acute pancreatitis. Chin. Med. J. (Engl.) 2010, 123, 1639–1644.
Zhao G, Zhang JG, Wu HS et al. Effects of different resuscitation fluid on severe acute pancreatitis. World J. Gastroenterol. 2013, 19, 2044–2052.
Van Santvoort HC, Bakker OJ, Bollen TL et al. A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology 2011, 141, 1254–1263.
Jacob AO, Stewart P. & Jacob O. Early surgical intervention in severe acute pancreatitis: Central Australian experience. ANZ J. Surg. 2016, 86, 805–810.
Tao J, Wang C, Chen L et al. Diagnosis and management of severe acute pancreatitis complicated with abdominal compartment syndrome. J Huazhong Univ Sci Technolog Med Sci, 23, 2003, 399–402.
Plantefève G, Cheisson G, Mahjoub Y et al. Le syndrome compartimental abdominal. Réanimation 2003, Vol. 12, 422–429.
Risse O, Arvieux C, Abba J et al. Chirurgie des complications des pancréatites aiguës – Encycl Med Chir, Techniques chirurgicales, Appareil Digestif, 2012, 40-885.
Cheatham ML, Malbrain MN, Kirkpatrick A et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med. 2007, 33, 951–962.
Ikeda S, Kagami T, Tani S et al. Decompressive laparotomy for abdominal compartment syndrome resulting from severe acute pancreatitis: a case report. BMC Gastroenterol. 2019, 19, 141.
Voiglio EJ, Dubuisson V, Massalou D et al. Place et technique de la laparotomie écourtée (LAPEC) ou « damage control laparotomy ». J Visc Surg. 2016;153(4 Suppl):13-24.
Miller PR, Meredith JW, Johnson JC et al. Prospective evaluation of vacuum-assisted fascial closure after open abdomen: planned ventral hernia rate is substantially reduced. Ann. Surg. 2004, 239, 608–614.
Leppäniemi A, Hienonen P, Mentula P et al. Subcutaneous linea alba fasciotomy, does it really work? Am. Surg. 2011, 77, 99–102.
Leppäniemi A, Mentula P, Hienonen P et al. Transverse laparostomy is feasible and effective in the treatment of abdominal compartment syndrome in severe acute pancreatitis. World J. Emerg. Surg. 2008, 3, 6.
Sugrue M. Abdominal compartment syndrome and the open abdomen: any unresolved issues? Curr. Opin. Crit. Care 2017, 23, 73–78.
Rogers WK & Garcia L. Intraabdominal Hypertension, Abdominal Compartment Syndrome, and the Open Abdomen. Chest 2018, 153, 238–250.
Mayberry JC, Burgess EA, Goldman RK et al. Enterocutaneous fistula and ventral hernia after absorbable mesh prosthesis closure for trauma: the plain truth. J. Trauma 2004 57, 157–162; discussion 163-163.
Oláh A & Romics L. Enteral nutrition in acute pancreatitis: a review of the current evidence. World J. Gastroenterol. 2014, 20, 16123–16131.
Sun JK, Li WQ, Ke L et al. Early enteral nutrition prevents intra-abdominal hypertension and reduces the severity of severe acute pancreatitis compared with delayed enteral nutrition: a prospective pilot study. World J. Surg. 2013, 37, 2053–2060.
Petrov MS, Pylypchuk RD & Uchugina, AF. A systematic review on the timing of artificial nutrition in acute pancreatitis. Br. J. Nutr. 2009, 101, 787–793.
L.J. De Waele, E. Verholen, E. Hoste, and De Laet. Patients who suffer from intra-abdominal hypertension and the effects of neuromuscular blockers. Intensive Care Medicine 33:1811–1814 in 2007. PMID: 17594072. Pancreatitis acute, 24553339 (PMID). 2014, Curr Opin Crit Care 20:189–19 573.
DeLegge MH. Enteral Access and Associated Complications. Gastroenterol. Clin. North Am. 2018, 47, 23–37.
Hernández-Aranda JC, Gallo-Chico B. & Ramírez-Barba EJ. [Nutritional support in severe acute pancreatitis. Controlled clinical trial]. Nutr. Hosp. 1996, 11, 160–166.
Ke . R, Ockenga J, Pertkiewicz M et al. ESPEN Guidelines on Enteral Nutrition: Pancreas. Clin. Nutr. Edinb. Scotl. 2006, 25, 275–284.
Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 2013, 13, e1-15.
Lambertz A, Mihatsch C, Röth A et al. Fascial closure after open abdomen: initial indication and early revisions are decisive factors—a retrospective cohort study. Int. J. Surg. Lond. Engl. 2015, 13, 12–16.
Bouillot JL, Poghosyan, T, Corigliano N et al. Management of voluminous abdominal incisional hernia. J. Visc. Surg 2012. 149, e53-58.
Poghosyan T, Veyrie N, Corigliano N et al. Retromuscular mesh repair of midline incisional hernia with polyester standard mesh: monocentric experience of 261 consecutive patients with a 5-year follow-up. World J. Surg. 2012, 36, 782–790.
Sabbagh C, Dumont F, Fuks D et al. Progressive preoperative pneumoperitoneum preparation (the Goni Moreno protocol) prior to large incisional hernia surgery: volumetric, respiratory and clinical impacts. A prospective study. Hernia. 2012, 16, 33–40.
J.B. Sun, Chen, F. Li, and J.G. Jia. abdominal compartment syndrome in the early stages in people with severe acute pancreatitis. PMID: 18567084. World Journal of Gastrology 14:3541–3548, 2008.
De Keulenaer, A. Regli, I. De Laet, D. Roberts, and M. Malbrain are the group. Emptying intra-abdominal contents, improving abdominal wall compliance, medicine, and maintaining consistent negative extra-abdominal pressure are the latest medical care techniques for high intra-abdominal pressure. 2015;47(1):54–62 in Anaesthesia and Intensive Care Medicine. PMID: 25421926.

No competing interests reported.

Download PDF

Version 1

posted

You are reading this latest preprint version

Prospetive evaluation of the risk of compartmental intra-abdominal pressure on mortality in severe acute pancreatitis

Status:

Version 1

Abstract

Figures

1 | BACKGROUND

2 | METHODS

3 | Data collection

4 | Statestical analysis

5 | RESULTS

6 | DISCUSSION

7 | CONCLUSIONS

Declarations

References

Additional Declarations

Status:

Version 1